SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility and intense community debate as investors react to its slide toward 52-week lows ahead of upcoming quarterly earnings. While the bullish community is highlighting strong product demand, successful international expansion, and the ongoing integration of the Alani Nu brand, bears are expressing concerns over slowing core brand momentum, margin pressure from commodity costs, and increased private-label competition.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is driving intense community debate following a mixed shelf offering filing and a rollercoaster earnings reaction that saw the stock swing violently between gains and losses. Investors are divided between those citing massive revenue growth, buyback strength, and AI-driven efficiency as a generational buying opportunity and those concerned by high intraday volatility and the potential for dilution.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors rally around the company's strong revenue growth and global expansion plans, while vocal community members actively speculate on an impending short squeeze despite ongoing regulatory pressures. The broader discussion is dominated by bullish sentiment regarding the potential for upcoming FDA catalysts and the company's proprietary technology, with many shareholders dismissing recent price volatility as manipulative tactics.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing significant investor frustration as earnings performance is overshadowed by concerns over executive leadership and disappointing commentary regarding future sales. Community sentiment is deeply divided, with many traders criticizing management's transparency while bargain hunters view the recent sell-off as an opportunity to accumulate shares at perceived value.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending following a report positioning the company as a key supplier for AI infrastructure, specifically regarding co-packaged optics components for major tech industry players. The community is actively debating the sustainability of this price action, with many closely tracking significant spikes in trading volume and options activity ahead of key industry conferences.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as investors react to a major leadership overhaul, with new CEO and largest shareholder Kevin Tang taking the helm to drive strategy and prioritize shareholder value. The community is actively discussing the recent acquisition of Kezar Life Sciences and the potential for a strategic buyout, fueling optimistic speculation about the company's future direction.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor interest following a strong first-quarter earnings report that featured a notable EPS beat and raised full-year net income guidance. The community is actively discussing the stock's potential for a breakout, driven by its underlying profitability, expanding institutional partnerships, and high short interest that has sparked speculation about a possible short squeeze.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is surging following a strong quarterly earnings report that featured a revenue beat and robust growth in its high-value customer base, signaling to investors that demand for AI-driven cloud monitoring remains resilient. While some traders are expressing caution after the significant price jump, the broader community sentiment is focused on the stock's role as a key infrastructure player in the expanding AI ecosystem.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant market volatility driven by strong Q1 2026 earnings that surpassed consensus estimates, despite ongoing pressure from short sellers and skepticism regarding the long-term uptake of its primary gene therapy. The community remains deeply polarized, with bulls pointing to the company's established commercial revenue and promising siRNA pipeline as evidence of extreme undervaluation, while bears continue to highlight historical regulatory challenges and questions surrounding long-term clinical efficacy.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as investors weigh strong demand for its high-energy silicon anode battery technology against ongoing volatility driven by warrant redemption mechanics. Community discussion is focused on the company's expanding order backlog in the defense and electric mobility sectors, with many traders closely monitoring whether the share price can maintain the critical support levels required to trigger warrant exercises.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iran War Fails to Dampen China Q1 Industrial Profit Jump: ETFs at Play

China's industrial profit surge puts the spotlight on ETFs like CQQQ as deflation ends and high-tech growth drives resilience amid global turmoil.

ETFs to Watch as China's Factory Deflation Comes to an End After 3 Years

China's factory deflation ends after 3 years as PPI turns positive, putting ETFs like MCHI in focus amid rising oil prices and a potential market rebound.

4 Reasons to Stay Cautious and Play ETFs Strategically

Slowing U.S. growth, rising oil prices and war risks are shaking markets. Here are key long-term ETF ideas to navigate volatility and build resilient portfolios.

The Iran Storm Bypasses China: Why Its ETFs Look Attractive Now

ETFs like MCHI draw attention as China's retail sales and industrial output beat expectations, signaling renewed economic momentum.

What Lies Ahead for China ETFs in the New Year of the Horse?

China ETFs enter the Year of the Horse with cheap valuations, AI momentum and policy support, but property woes, weak consumption and geopolitics may keep volatility elevated.

Time for China ETFs Now?

China ETFs are back in focus as easing policy, resilient exports and Goldman's bullish outlook lift tech and large caps like FXI, CQQQ and ECNS.

<ul class="summary-bullets"><li>These are aimed at improving China's modern infrastructure system and supporting a smooth start to the 15th Five-Year Plan (2026-2030), according to a Reuters report.&nbsp; About 220 billion yuan has been set aside for 281 national and security-related projects, as per the report.&nbsp; In a separate statement, the National Development and Reform Commission said that the country’s top leadership is prioritizing expanding domestic demand as one of its eight key tasks for 2026.</li></ul>China is reportedly allocating 295 billion yuan ($42.16 billion) in 2026 on an investment plan for the central government's budget and major projects amid the country’s increasing focus on expanding domestic demand and stimulating consumption and investment.According to a Reuters report from Wednesday, the projects are aimed at improving China's modern infrastructure system and supporting a smooth start to the 15th Five-Year Plan (2026-2030), Li Chao, a National Development and Reform Commission (NDRC) spokesperson, said in Beijing.The announcement comes even as China’s top leadership lists expanding domestic demand as one of its eight key tasks for 2026, alongside prioritizing the refinement of the “Two New” policies to build a more robust domestic market, as per a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251231_1402889.html">separate statement</a> from NDRC.<h2 class="st-heading-2">Investment Allocation</h2>Li Chao, a spokesperson for the National Development and Reform Commission, said in Beijing that about 220 billion yuan has been set aside for 281 national and security-related projects, according to the report.Additionally, the central government has set aside over 75 billion yuan to fund 673 projects across domains such as ecological protection and carbon reduction.China's "Two New" policies, namely equipment renewal and consumer goods trade-in, aim to bolster domestic demand while simultaneously improving equipment efficiency to lower emissions. President Xi Jinping reiterated the idea in early 2024 as a way for the government to shift China's growth towards domestic demand while strengthening internal infrastructure, energy, and resource security.China has also <a href="https://stocktwits.com/news-articles/markets/equity/china-announces-first-tranche-of-nearly-9-billion-in-consumer-subsidies-for-2026/cL7IRShREUH">announced</a> the first tranche of 62.5 billion yuan ($8.92 billion) in subsidies, to be provided through the sale of ultra-long special sovereign bonds to local governments, to support the trade-in of consumer goods in 2026.<h2 class="st-heading-2">Future Outlook</h2>The government’s investment plans and 15th Five-Year Plan come as the world’s second-largest economy faces headwinds from a persistent property slump, weak consumer demand, and global trade tensions.While China’s year-to-date GDP growth came in at 5.2% year-on-year as of December, it is projected to grow at 4.4% in 2026, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.worldbank.org/en/news/press-release/2025/12/11/advancing-reforms-can-enhance-prospects-china-economic-update">report</a> from the World Bank, which also believes that the country’s growth in the coming years hinges on the strength of its domestic demand as well as its structural reforms.The <a href="https://stocktwits.com/symbol/FXI">iShares China Large-Cap ETF</a> (FXI), which tracks large-capitalization Chinese equities, has climbed over 25% in the past year. Meanwhile, U.S. equities declined in Wednesday morning’s trade.At the time of writing, the <a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was down 0.23%, while the <a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) edged 0.31% lower. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘neutral’ territory.The <a href="https://stocktwits.com/symbol/IEF">iShares 7-10 Year Treasury Bond ETF</a> (IEF) was up 0.10% at the time of writing.For updates and corrections, email newsroom[at]stocktwits[dot]com.(1 Chinese Yuan = $0.14) &nbsp;

Used cars sold in a used car market in Yichang, Hubei Province, China on June 9, 2025. (Photo credit should read CFOTO/Future Publishing via Getty Images)

China Reportedly Earmarks $42 Billion For 2026 Projects – Infrastructure, Consumption Take Priority

China’s 295 billion yuan allocation in 2026 will go towards an investment plan for the central government's budget and other major projects. 

Equity

Top-Performing International ETFs of 2025

International ETFs like VEA, EZU & EEM outshone U.S. peers in 2025 as cheaper valuations, diversified exposure, and stimulus measures drove substantial gains.

<ul class="summary-bullets"><li>“When the animal spirits are kicking in and when there is a clear advantage being struck by winning companies, they want alpha,” — Pick.</li><li>Earlier, Goldman Sachs CEO David Solomon said that there is a greater appetite for investments in Chinese companies than 12 months ago, after valuations became more attractive.</li><li>Pick further stated that China is offering a blueprint to its neighbor, India, to build its own global industry champions and homegrown leaders.</li></ul>Morgan Stanley CEO Ted Pick reportedly said on Tuesday that China has held its place as a top draw for global asset managers amid a return of confidence, with investors agreeing that the world’s second-most liquid market is too big to ignore.According to a Bloomberg News <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-04/morgan-stanley-ceo-says-asset-managers-want-china-exposure">report</a> citing a television interview with Pick, the Wall Street lender’s top boss said that asset managers were underweight on China, with exposure becoming more passive and beta-driven when times were tough, and that it has once again become a destination for investment, with momentum returning.<h2 class="st-heading-2">Wall Street CEOs Acknowledge Return Of The ‘Alpha’</h2>Speaking on the sidelines of Hong Kong’s annual financial summit, Pick joined a rising number of Wall Street banks and asset managers to express enthusiasm for the world’s second biggest economy after a few years of slowdown following strict pandemic restrictions, regulatory crackdowns, and real estate turmoil.Beijing has stepped in increasingly to bolster economic growth by injecting liquidity, easing foreign inflows, and offering incentives to boost consumption amid the uncertain economic policies of the Trump administration, which have affected its exports.<blockquote>“When the animal spirits are kicking in and when there is a clear advantage being struck by winning companies, they want alpha,” Pick reportedly said. “They want company-specific allocations — that’s when the new-issue environment becomes so important.”</blockquote>The iShares China Large-Cap ETF has jumped 32.6% this year, and the iShares MSCI China ETF has risen over 37%. This compares with nearly 16% gains in the SPDR S&amp;P 500 ETF and over 22% rise in Invesco QQQ Trust Series 1 ETF, which tracks the Nasdaq 100 companies.Retail sentiment on Stocktwits about the <a href="https://stocktwits.com/symbol/FXI">iShares China Large-Cap ETF</a> (FXI) was in the ‘bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:795/99;" src="https://news.stocktwits-cdn.com/FXI_Nov_4_JPG_14e9276cb2.webp" alt="FXI’s Sentiment Meter and Message Volume as of 03:05 a.m. ET on Nov. 4, 2025 | Source: Stocktwits" width="795" height="99"><figcaption>FXI’s Sentiment Meter and Message Volume as of 03:05 a.m. ET on Nov. 4, 2025 | Source: Stocktwits</figcaption></figure>Earlier, Goldman Sachs CEO David Solomon said that there is a greater appetite for investments in Chinese companies than 12 months ago, after valuations became more attractive.India Moving Beyond ‘Plus-One’ StatusPick further stated that China is offering a blueprint to its neighbor, India, to build its own global industry champions and homegrown leaders that can transform its economy. Asia's third-largest economy is learning to move beyond its “plus-one” status and begin creating its own international leaders, he reportedly added.He added that for Morgan Stanley, the two markets are among the most exciting places to operate, with each offering scale, ambition, and a growing roster of companies ready to compete on the world stage. “I like India, but I like China. You don’t have to make the choice,” he said.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/state-street-chief-o-hanley-dubs-trump-s-immigration-policies-anti-growth/cL282uoR3Cl">State Street Chief O’Hanley Dubs Trump’s Immigration Policies ‘Anti-Growth’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A view of the Chinese National Flag. On Wednesday, 27 September 2017, in Badaling, Yanqing District, Beijing, China. (Photo by Artur Widak/NurPhoto via Getty Images)

Morgan Stanley Chief Ted Pick Proclaims China As Top Draw For Asset Managers

The Wall Street lender’s top boss said that asset managers were underweight on China when times were tough, and that it has once again become a destination for investment.

ETFs in Focus as China's Economic Growth Slows in Q3

China's GDP slows to 4.8%, raising hopes of policy easing. Likely rate cuts may drive ETFs like KWEB, CQQQ, FXI & MCHI in the coming months.

iShares Trust - iShares China Large-Cap ETF

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

FXI
iShares China Large-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest FXI News

FXIiShares China Large-Cap ETF